Together, the current findings of the study suggest a therapeutic potential of treadmill running in treating obesity phenotypes and decreased voluntary locomotion associated with D2R deficiency or HFD or a combination of D2R deficiency and HFD. This evidence concerns the gene DRD2 and obesity due to melanocortin 4 receptor deficiency.